Furthermore, pretreatment with anti–IFN-γ or anti–TNF-α monoclonal antibodies (mAbs), or IFN-γ gene ablation confers protection against Con A-induced hepatitis, indicating that Th1-dependent cytokines are also involved [9]–[12]. The gene discussed is TNF; the disease is hepatitis A virus infection.